The United States signed a bilateral health cooperation Memorandum of Understanding with the Royal Government of Cambodia through the Trump Administration’s America First Global Health Strategy, according to an April 6 announcement. The five-year agreement is the first of its kind in Asia under this initiative and aims to advance joint global health goals such as preventing the spread of infectious diseases including HIV/AIDS, malaria, and tuberculosis.
The new phase in U.S.-Cambodia collaboration matters because it seeks to strengthen Cambodia's capacity to prevent and respond to infectious disease threats before they become international crises. The agreement is also designed to ensure that progress made through previous U.S. global health support is maintained and becomes more locally owned by Cambodian authorities.
Under the terms of the memorandum, the Department of State intends to provide over $30.8 million in support for Cambodian efforts to detect pathogens with epidemic or pandemic potential. In return, Cambodia has committed more than $5.3 million from its own budget towards domestic expenditures and will take greater responsibility for managing supply chains while continuing deployment of diagnostics, vaccines, drugs, and other interventions.
The total value of this bilateral MOU stands at $36.1 million and includes $5 million specifically allocated for global health security funding intended to strengthen laboratory networks in Cambodia. One goal highlighted in the agreement is achieving malaria elimination within the country while fostering independent leadership over its national health system.
According to information released by officials, similar memoranda signed so far represent over $20.5 billion in new global health funding worldwide—$12.7 billion from U.S assistance along with $7.8 billion from recipient countries themselves—covering work against HIV/AIDS, malaria, tuberculosis, and other diseases across multiple continents.
